Want to create an interactive transcript for this episode?
Podcast: Podcasts360
Episode: Susan Hutchinson, MD, on Oral Rimegepant in Adults With Migraine and Cardiovascular Risk Factors
Description: In this podcast, Susan Hutchinson, MD, discusses the implications for her team's research presented in the session "Oral Rimegepant 75 mg is Safe and Well Tolerated in Adults With Migraine and Cardiovascular Risk Factors: Results of a Multicenter, Long-Term, Open-Label Safety Study" at the American Academy of Neurology's 2021 Virtual Annual Meeting.